Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting Transcript
Ladies and gentlemen, welcome to the Ultragenyx Pharmaceutical 2020 Annual Shareholder Meeting.
I will now turn things over to Chairman, Dan Welch.
Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of Stockholders of Ultragenyx Pharmaceutical Inc. My name is Dan Welch, and I serve as the Chairman of the Board. I'll be presiding over this meeting.
At this time, I call the meeting to order. Emil Kakkis, the President and CEO, is present and will walk us through the rest of the meeting. Emil?
Thank you, Dan. Joining us today are Bill Aliski, Chair of the Compensation Committee; Lars Ekman, Chair of the Research and Development Committee; Matt Fust, Chair of the Audit and Nominating and Corporate Governance Committee; Michael Narachi, Director; Shehnaaz Suliman, Director; Karah Parschauer, Executive Vice President
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |